论文部分内容阅读
目的:观察中医清肺汤联合西医常规治疗老年慢性肺炎的临床疗效。方法:选取我院呼吸内科2011年9月~2013年8月收治的120例老年慢性肺炎患者随机分为治疗组和对照组各60例,对照组采用常规西医抗感染治疗,治疗组在对照组的基础上联用中医方剂益肺汤治疗,比较两组患者治疗前与2周后两组患者的外周血实验室指标白细胞(WBC)、中性粒细胞、白细胞介素-2(IL-2)、γ-干扰素(IFN-γ)、白细胞介素-4(IL-4)、白细胞介素-10(IL-10)水平及疗效差异。结果:治疗组和对照组的WBC、中性粒细胞、IL-2、IFN-γ、IL-4、IL-10治疗后与治疗前比较差异均具有统计学意义(P<0.05);治疗后治疗组和对照组IL-2、IFN-γ、IL-4、IL-10差异均具有统计学意义(P<0.05)。治疗组的临床疗效分布显著优于对照组且差异具有统计学意义(P<0.05);治疗组的总有效率91.67%高于对照组的85%但差异不具有统计学意义(P>0.05)。结论:中医清肺汤联合西医常规治疗老年慢性肺炎较单用西医疗法具有跟显著的临床疗效。
Objective: To observe the clinical efficacy of Qingfei Decoction combined with western medicine in the treatment of senile chronic pneumonia. Methods: A total of 120 elderly patients with chronic pneumonia admitted to our hospital from September 2011 to August 2013 were randomly divided into treatment group (60 cases) and control group (60 cases). The control group was treated with conventional Western medicine and the control group Based on the combination of Chinese medicine prescription Yifei Tang treatment, two groups of patients before treatment and two weeks after the comparison of the peripheral blood leukocytes (WBC), neutrophils, interleukin-2 (IL-2 (IFN-γ), interleukin-4 (IL-4) and interleukin-10 (IL-10) Results: The WBC, neutrophil, IL-2, IFN-γ, IL-4 and IL-10 in treatment group and control group were significantly different from those before treatment (P <0.05) The difference of IL-2, IFN-γ, IL-4 and IL-10 in the treatment group and the control group were statistically significant (P <0.05). The clinical efficacy of the treatment group was significantly better than that of the control group (P <0.05). The total effective rate of the treatment group was 91.67% higher than that of the control group (85%), but the difference was not statistically significant (P> 0.05) . Conclusion: Traditional Chinese medicine Qingfei Decoction combined with Western conventional treatment of chronic obstructive pulmonary disease than Western medicine alone with significant clinical efficacy.